首页> 外文期刊>Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides >beta-Cyclodextrin-modified hyaluronic acid-based supramolecular self-assemblies for pH- and esterase-dual-responsive drug delivery
【24h】

beta-Cyclodextrin-modified hyaluronic acid-based supramolecular self-assemblies for pH- and esterase-dual-responsive drug delivery

机译:β-环糊精改性的基于透明质酸的超分子自组装,用于pH-和酯酶 - 双响应药物递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although some drug-based supramolecular systems have been constructed to overcome multidrug resistance and enhance the bioavailability of chemical drugs, strengthening the specific stimuli-responsive and active targeting ability of these systems is still a major challenge. In this paper, the synthesis and self-assembly behaviour of supramolecular self-assemblies with active targeting beta-cyclodextrin-modified hyaluronic acid (HA-CD) and drug-drug conjugates (curcumin-oxoplatin, Cur-Pt) as building moieties were carefully investigated. Notably, the curcumin was chosen not only as the chemical anti-cancer drug, but also acted as the guest molecule which could be included into CD cavity to form host-guest interaction-based supramolecular assemblies. The obtained self-assemblies exhibited pH- and esterase-responsive drug release behaviours. Furthermore, basic cell experiments were performed to prove their effective cellular toxicity based on A549 cells and PC3 cells with high expression of CD44 receptor but they showed no toxicity to normal LO-2 cells with low expression of CD44 receptor, which suggests their potential application in the targeted drug release field.
机译:尽管已经构建了一些基于药物的超分子系统以克服多药耐药性并增强化学药物的生物利用度,但增强这些系统的特异性刺激响应性和积极的靶向能力仍然是一个重大挑战。本文在仔细仔细地,用活性靶向β-环糊精改性透明质酸(HA-CD)和药物 - 药物缀合物(姜黄素 - 氧代丁)和药物 - 药物缀合物(姜黄素 - 氧代丁)和药物 - 药物缀合物(姜黄素 - 氧化蛋白,Cur-Pt)的合成和自组装行为进行仔细调查。值得注意的是,姜黄素不仅选择为化学抗癌药物,而且还可作为客体分子作为可包括在Cd腔中以形成基于宿主的相互作用的超分子组件。所获得的自组装表现出pH-和酯酶响应释放行为。此外,进行基于CD44受体的高表达的A549细胞和PC3细胞的基于A549细胞和PC3细胞来证明其有效细胞毒性,但它们对CD44受体表达低表达的正常LO-2细胞没有毒性,这表明其潜在的应用靶向药物释放领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号